BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19887915)

  • 1. Myc's secret life without Max.
    Gallant P; Steiger D
    Cell Cycle; 2009 Dec; 8(23):3848-53. PubMed ID: 19887915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Max-independent functions of Myc in Drosophila melanogaster.
    Steiger D; Furrer M; Schwinkendorf D; Gallant P
    Nat Genet; 2008 Sep; 40(9):1084-91. PubMed ID: 19165923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc phosphorylation in its basic helix-loop-helix region destabilizes transient α-helical structures, disrupting Max and DNA binding.
    Macek P; Cliff MJ; Embrey KJ; Holdgate GA; Nissink JWM; Panova S; Waltho JP; Davies RA
    J Biol Chem; 2018 Jun; 293(24):9301-9310. PubMed ID: 29695509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila Myc: A master regulator of cellular performance.
    Grifoni D; Bellosta P
    Biochim Biophys Acta; 2015 May; 1849(5):570-81. PubMed ID: 25010747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc and Max function as a nucleoprotein complex.
    Blackwood EM; Kretzner L; Eisenman RN
    Curr Opin Genet Dev; 1992 Apr; 2(2):227-35. PubMed ID: 1638116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
    Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mnt: master regulator of the Max network.
    Nilsson JA; Cleveland JL
    Cell Cycle; 2004 May; 3(5):588-90. PubMed ID: 15107624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC on the path to cancer.
    Dang CV
    Cell; 2012 Mar; 149(1):22-35. PubMed ID: 22464321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
    Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
    Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myc and Max homologs in Drosophila.
    Gallant P; Shiio Y; Cheng PF; Parkhurst SM; Eisenman RN
    Science; 1996 Nov; 274(5292):1523-7. PubMed ID: 8929412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and regulation of the transcription factors of the Myc/Max/Mad network.
    Lüscher B
    Gene; 2001 Oct; 277(1-2):1-14. PubMed ID: 11602341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila Myc.
    Gallant P
    Adv Cancer Res; 2009; 103():111-44. PubMed ID: 19854354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p14ARF directly interacts with Myc through the Myc BoxII domain.
    Amente S; Gargano B; Varrone F; Ruggiero L; Dominguez-Sola D; Lania L; Majello B
    Cancer Biol Ther; 2006 Mar; 5(3):287-91. PubMed ID: 16410719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule modulators of c-Myc/Max and Max/Max interactions.
    Berg T
    Curr Top Microbiol Immunol; 2011; 348():139-49. PubMed ID: 20680803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural aspects of interactions within the Myc/Max/Mad network.
    Nair SK; Burley SK
    Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
    PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Max-imizing the Attenuation of Myc Using Small Molecules.
    Boyd SR; Young DW
    Trends Pharmacol Sci; 2019 Sep; 40(9):608-612. PubMed ID: 31280901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.